Joshua Cohen
Signal active
CEO and Founder
Contact Information
Social
Primary Organization
Amylyx Pharmaceuticals
Founded
2014
Employees
251-500
Industry
Biotechnology, Pharmaceutical, Medical, Neuroscience
Bio
Josh Cohen co-founded Amylyx Pharmaceuticals in 2013 and has served since that time as its Co-CEO, its Co-Founder, and as Chairman of the board of directors. Josh co-invented AMX0035 and has overseen the growth of Amylyx from its start as a concept dreamed up in a dorm room to its status now as a pre-commercial stage pharmaceutical company. Together with Justin, Josh has raised nearly $250M in financing to support the development of new therapies for ALS and other neurodegenerative diseases. Josh received his Bachelor of Science in Biomedical Engineering from Brown University.
Location
Canton, Massachusetts, United States, North America
Jobs history
0
N/A
Educations
1
Brown University
Biomedical Engineering
Profile Resume
Joshua Cohen is the CEO and Founder at Amylyx Pharmaceuticals, based in United States, North America. With a background in Biotechnology, Joshua Cohen has a rich history of leadership and innovation.Joshua Cohen studied Bachelors Biomedical Engineering at Brown University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.